Back to Tudor Investment Corp. Tudor Investment Corp.

IOVAIOVA

Showing 8 of 24 quarters

Position history for Tudor Investment Corp.Tudor Investment Corp.'s holdings in Iovance Biotherapeutics, Inc.

Yes. Tudor Investment holds 293,989 shares of IOVA (Iovance Biotherapeutics), worth $1.2M, as of its Q2 2026 13F filing. It increased the position by 77,985 shares (+36.1%) from Q1 2026. Tudor Investment has held IOVA since Q3 2025, across 4 quarterly 13F filings.

Current Value

$1.2M

Current Shares

293,989

Total Value Change

-$832,731

Total Shares Change

+75,062

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
293,989
+36.1%
$1.2M0.0%$4.16
33
2026-Q1
Increased
216,004
+20.3%
$758,1740.0%$3.51
29
2025-Q4
Increased
179,494
+47.4%
$490,0190.0%$2.73
33
2025-Q3
New
121,744
—
$264,1840.0%$2.17
32
2025-Q2
Exited
0
-100.0%
$00.0%$1.72
0
2025-Q1
New
122,930
—
$409,3570.0%$3.33
33
2024-Q4
Exited
0
-100.0%
$00.0%$7.40
0
2024-Q3
Decreased
218,927
-27.0%
$2.1M0.0%$9.39
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used